Get Your Business Started With Flat Responsive

Use Flat Responsive theme to create your business website as it is SEO optimized.
Enjoy the flexibility in design and functionality provided by this theme.

Get Theme

Brookhaven Lab and BioSET, Inc., Patent a Synthetic Peptide That Enhances Bone Growth

Brookhaven Science Associates, the company that operates and manages the U.S. Department of Energy’s Brookhaven National Laboratory (BNL), and Biosurface Engineering Technologies, Inc. (BioSET), have been issued a U.S. patent on a synthetic peptide, called B2A. B2A enhances the effects of a tissue growth factor known as bone morphogenetic protein 2, or BMP-2. BMPs are a family of proteins in the human body responsible for the proliferation, repair and differentiation of cells in many tissues, including bone. Tom Rouche, BioSET President and CEO said “We have developed a novel combination medical device, called AMPLEX, that incorporates B2A osteo-inductive growth factor with an ultra-high grade ceramic bone substitute for use in this type of surgery. Preclinical studies have found that it is a safe and highly effective.”

Leave a Reply

Your email address will not be published. Required fields are marked *